Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7571400

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
As at
2018-12-31
As at
2018-12-31
2018-01-01 to
2018-12-31
2018-01-01 to
2018-12-31
Key financial data of group
Business results of group
Net sales
1,386,748,000 JPY
1,216,066,000 JPY
1,931,718,000 JPY
2,017,529,000 JPY
1,133,346,000 JPY
1,042,960,000 JPY
3,207,423,000 JPY
3,070,843,000 JPY
754,691,000 JPY
640,711,000 JPY
Ordinary profit (loss)
-1,278,820,000 JPY
-1,357,020,000 JPY
-548,843,000 JPY
-522,992,000 JPY
-1,077,096,000 JPY
-1,096,348,000 JPY
957,161,000 JPY
874,478,000 JPY
-1,159,223,000 JPY
-1,156,637,000 JPY
Profit (loss) attributable to owners of parent
-1,349,539,000 JPY
-534,474,000 JPY
-1,111,032,000 JPY
828,289,000 JPY
-1,210,573,000 JPY
Comprehensive income
-1,331,861,000 JPY
-510,976,000 JPY
-1,119,890,000 JPY
830,764,000 JPY
-1,212,712,000 JPY
Net assets
3,641,844,000 JPY
3,439,714,000 JPY
4,194,643,000 JPY
4,315,572,000 JPY
3,741,428,000 JPY
3,824,010,000 JPY
3,853,522,000 JPY
3,781,463,000 JPY
900,044,000 JPY
887,453,000 JPY
Total assets
4,266,453,000 JPY
4,046,289,000 JPY
5,305,486,000 JPY
5,432,560,000 JPY
4,748,867,000 JPY
4,835,356,000 JPY
5,376,610,000 JPY
5,302,570,000 JPY
1,780,565,000 JPY
1,770,090,000 JPY
Net assets per share
255.04
240.82
314.45
323.54
301.39
308.05
329.86
323.68
88.07
86.83
Basic earnings (loss) per share
-99.10
-103.20
-43.83
-42.10
-90.33
-91.84
76.05
68.47
-125.02
-123.85
Diluted earnings per share
74.51
67.08
Equity-to-asset ratio
0.850 xbrli:pure
0.846 xbrli:pure
0.789 xbrli:pure
0.793 xbrli:pure
0.787 xbrli:pure
0.790 xbrli:pure
0.715 xbrli:pure
0.711 xbrli:pure
0.501 xbrli:pure
0.497 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
0.351 xbrli:pure
0.320 xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
27.9 xbrli:pure
31.0 xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-708,390,000 JPY
-1,536,612,000 JPY
-1,260,972,000 JPY
1,477,773,000 JPY
-1,128,026,000 JPY
Net cash provided by (used in) investing activities
-125,696,000 JPY
-41,677,000 JPY
-70,433,000 JPY
-40,945,000 JPY
-58,314,000 JPY
Net cash provided by (used in) financing activities
367,006,000 JPY
1,064,987,000 JPY
724,423,000 JPY
2,121,748,000 JPY
687,522,000 JPY
Cash and cash equivalents
3,379,048,000 JPY
3,817,834,000 JPY
4,299,142,000 JPY
4,915,056,000 JPY
1,355,254,000 JPY
Number of employees
65 xbrli:pure
62 xbrli:pure
23 xbrli:pure
34 xbrli:pure
8 xbrli:pure
8 xbrli:pure
33 xbrli:pure
21 xbrli:pure
61 xbrli:pure
64 xbrli:pure
61 xbrli:pure
64 xbrli:pure
63 xbrli:pure
60 xbrli:pure
58 xbrli:pure
62 xbrli:pure
Average number of temporary employees
8 xbrli:pure
8 xbrli:pure
4 xbrli:pure
3 xbrli:pure
1 xbrli:pure
1 xbrli:pure
3 xbrli:pure
4 xbrli:pure
9 xbrli:pure
9 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
4 xbrli:pure
2 xbrli:pure
2 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.